Written by Sean Waldron | Sep 25, 2026, 10:00:00 AM
USP is seeking pharmacist feedback on a proposed risk-based framework for evaluating and validating alternative technologies under USP <797>.Read the article with a free USP–NF account and submit comments by November 30, 2026.